Himadri
-
{
- All
- News
- Videos
- Web Stories
-
Beaten Down, Not Out: Top Five Stocks That Made A December Comeback
These heavy underperformers between January and November posted notable gains in December.
-
Dealing Room Buzz: Biocon, Cipla, Himadri Speciality, Apollo Hospital, Suzlon, M&M, Kaynes Tech
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Biocon, Cipla, Himadri Speciality, Apollo Hospital, Suzlon, M&M and Kaynes Tech.
-
Five Stocks To Buy Today: BHEL, ITC Hotels, ICICI Pru Life, Ceat Among Others
Brijesh Ail, head technical and derivatives, retail research IDBI Capital recommended buying Ceat at the current market price.
-
Mid-Cap Stocks To Buy, Sell, Hold: HPCL, Ramkrishna Forgings, Himadri Speciality Chemical — Check Target Price
Vaishali Parekh sees HPCL as a top pick for long term and short term investment.
-
'Buy' EPL, 'Hold' SRF Among Others Lists ICICI Securities Ahead Of Specialty Chemicals Q1 Results
Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming, adds ICICI Securities
-
Specialty Chemicals Q4 Results Preview: ICICI Securities Expect Fewer EPS Downgrades
Ebitda, on a low base, should grow 33% YoY/23.4% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemical, Archean and BlueJet likely outperforming, adds the brokerage.
-
Himadri Specialty Gets 'Add' As ICICI Securities Initiates Coverage, Sees Business Moats Getting Stronger
Himadri’s strong moat in the coal tar value chain complemented by an integrated production model allows it a firm grasp to maximise profits, says ICICI Securities.
-
Himadri Specialty Gets 'Add' As ICICI Securities Initiates Coverage, Sees Business Moats Getting Stronger
Himadri’s strong moat in the coal tar value chain complemented by an integrated production model allows it a firm grasp to maximise profits, says ICICI Securities.
-
Diwali Muhurat Stock Picks 2024: BEL To BHEL Among PL Capital's Top Stocks To Buy This Samvat 2081
Take a look at the top stocks picks by PL Capital for Samvat 2081.
-
Diwali Muhurat Stock Picks 2024: BEL To BHEL Among PL Capital's Top Stocks To Buy This Samvat 2081
Take a look at the top stocks picks by PL Capital for Samvat 2081.
-
Himadri Specialty Chemicals - Profit To Double In Three Years, With Better Margins, RoCE: Anand Rathi
At the Rs 390 ruling price, the stock trades at 47 times FY24 EPS.
-
Himadri Speciality To Set Up India's First Lithium Iron Phosphate Plant
With no presence of nickel and cobalt in the LFP battery, the cost is expected to drop exponentially.
-
Himadri Speciality To Set Up India's First Lithium Iron Phosphate Plant
With no presence of nickel and cobalt in the LFP battery, the cost is expected to drop exponentially.
-
IndusInd Bank Posts 30% Rise In Q1 Profit, L&T Tech Reports A Decline — Earnings Wrap
Here are the earnings of major companies announced after market hours on July 18.
-
Specialty Chemicals Sector Check - Lackluster R&D Expenses: Motilal Oswal
The absence of sufficient R&D spend is likely to challenge the sustainability of rich valuations that the companies are commanding
-
Beaten Down, Not Out: Top Five Stocks That Made A December Comeback
These heavy underperformers between January and November posted notable gains in December.
-
Dealing Room Buzz: Biocon, Cipla, Himadri Speciality, Apollo Hospital, Suzlon, M&M, Kaynes Tech
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Biocon, Cipla, Himadri Speciality, Apollo Hospital, Suzlon, M&M and Kaynes Tech.
-
Five Stocks To Buy Today: BHEL, ITC Hotels, ICICI Pru Life, Ceat Among Others
Brijesh Ail, head technical and derivatives, retail research IDBI Capital recommended buying Ceat at the current market price.
-
Mid-Cap Stocks To Buy, Sell, Hold: HPCL, Ramkrishna Forgings, Himadri Speciality Chemical — Check Target Price
Vaishali Parekh sees HPCL as a top pick for long term and short term investment.
-
'Buy' EPL, 'Hold' SRF Among Others Lists ICICI Securities Ahead Of Specialty Chemicals Q1 Results
Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming, adds ICICI Securities
-
Specialty Chemicals Q4 Results Preview: ICICI Securities Expect Fewer EPS Downgrades
Ebitda, on a low base, should grow 33% YoY/23.4% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemical, Archean and BlueJet likely outperforming, adds the brokerage.
-
Himadri Specialty Gets 'Add' As ICICI Securities Initiates Coverage, Sees Business Moats Getting Stronger
Himadri’s strong moat in the coal tar value chain complemented by an integrated production model allows it a firm grasp to maximise profits, says ICICI Securities.
-
Himadri Specialty Gets 'Add' As ICICI Securities Initiates Coverage, Sees Business Moats Getting Stronger
Himadri’s strong moat in the coal tar value chain complemented by an integrated production model allows it a firm grasp to maximise profits, says ICICI Securities.
-
Diwali Muhurat Stock Picks 2024: BEL To BHEL Among PL Capital's Top Stocks To Buy This Samvat 2081
Take a look at the top stocks picks by PL Capital for Samvat 2081.
-
Diwali Muhurat Stock Picks 2024: BEL To BHEL Among PL Capital's Top Stocks To Buy This Samvat 2081
Take a look at the top stocks picks by PL Capital for Samvat 2081.
-
Himadri Specialty Chemicals - Profit To Double In Three Years, With Better Margins, RoCE: Anand Rathi
At the Rs 390 ruling price, the stock trades at 47 times FY24 EPS.
-
Himadri Speciality To Set Up India's First Lithium Iron Phosphate Plant
With no presence of nickel and cobalt in the LFP battery, the cost is expected to drop exponentially.
-
Himadri Speciality To Set Up India's First Lithium Iron Phosphate Plant
With no presence of nickel and cobalt in the LFP battery, the cost is expected to drop exponentially.
-
IndusInd Bank Posts 30% Rise In Q1 Profit, L&T Tech Reports A Decline — Earnings Wrap
Here are the earnings of major companies announced after market hours on July 18.
-
Specialty Chemicals Sector Check - Lackluster R&D Expenses: Motilal Oswal
The absence of sufficient R&D spend is likely to challenge the sustainability of rich valuations that the companies are commanding
